Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN) in a note issued to investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock.

Separately, Lake Street Capital cut their price target on shares of Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, August 23rd.

Evogene Trading Up 19.9 %

EVGN opened at $3.07 on Tuesday. The company has a market cap of $126.53 million, a P/E ratio of -6.67 and a beta of 1.40. The company’s 50 day moving average is $3.65 and its 200-day moving average is $5.81. Evogene has a 1-year low of $2.29 and a 1-year high of $10.40.

Evogene (NASDAQ:EVGN) last released its quarterly earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.94). Evogene had a negative return on equity of 72.33% and a negative net margin of 210.26%. The firm had revenue of $0.91 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Evogene stock. BNP Paribas Financial Markets grew its stake in shares of Evogene Ltd. (NASDAQ:EVGN) by 30.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 91,400 shares of the biotechnology company’s stock after acquiring an additional 21,500 shares during the period. BNP Paribas Financial Markets owned 0.22% of Evogene worth $69,000 at the end of the most recent reporting period. Institutional investors own 10.40% of the company’s stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.